We use cookies to make your experience on this website better.

Our website contains information, graphics, data and materials intended for B2B clients, agencies, suppliers, distributors, stores and is not intended for the end-users or customers.

The statements on this website has not been evaluated by the Food and Drug Administration.

The Products and ingredients are not intended to diagnose, treat, cure or prevent any disease. If you continue to read, view and use the information, you accept our Terms and Conditions.

  • Japanese
Theravalues
  • About Us
  • Products
    • Theracurmin®
    • Theracurmin Super®
  • Trade Shows
  • Clinical Evidence
  • Learn
  • Contact

Absorption/Bioavailability

Filter by:

Reset
Search By:

Innovative preparation of curcumin for improved oral bioavailability.

Bioavailability

Learn More

Innovative preparation of curcumin for improved oral bioavailability.

Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T.

Biol Pharm Bull. 2011; 34 (5): 660-665.

TC001

Pre-Clinical

Clinical

Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects.

Bioavailability

Learn More

Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects.

Chung H, Yoon SH, Cho JY, Yeo HK, Shin D, Park JY.

International Journal of Clinical Pharmacology and Therapeutics. 2021 Oct; 59(10): 684-690.

 

TC0047

Clinical

Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.

Bioavailability

Learn More

Drinkable preparation of Theracurmin exhibits high absorption efficiency–a single-dose, double-blind, 4-way crossover study.

Bioavailability

Learn More

Drinkable preparation of Theracurmin exhibits high absorption efficiency–a single-dose, double-blind, 4-way crossover study.

Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K.

Biol Pharm Bull. 2013; 36 (11): 1708-1714.

TC011

Clinical

Theravalues
Products
  • Theracurmin®
  • Theracurmin Super®
Company
  • About
  • Safety
  • Trade Shows
  • Contact
Learn
  • Clinical Evidence
  • News
Contact
Japan

2F VORT Hirakawacho 1-5-15 Hirakawacho,
Chiyoda-ku, Tokyo,102-0093 Japan

Tel: +81-3-3234-7677

Canada

13353 Commerce Parkway, Unit 2353 3F
Richmond, BC, V6V3A1, CANADA

Tel: +1-604-207-2198

info@theravalues.ca

These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.

© 2025 Theravalues. All rights reserved.

  • Privacy Policy
  • Terms And Conditions
Canada

13353 Commerce Parkway, Unit 2353 3F
Richmond, BC, V6V3A1, CANADA

Tell: +1-604-207-2198

info@theravalues.ca